Inventor · disambiguated record
Joelle Lorraine Burgess
Also filed as: BURGESS JOELLE L · BURGESS JOELLE LORRAINE
17 granted patents·7 pending applications·181 citations·filing 1998–2018
94Inventor score
Files withGLAXOSMITHKLINE LLC6SMITHKLINE BEECHAM CORP6ADAMS NICHOLAS D3GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD3BURGESS JOELLE LORRAINE2
Top patents by PatentIndex Score
24 records- 0195US9562041B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE LLC·Filed 2013·Granted Feb 7, 2017·13 cites·1 claims
- 0289US8975291B2IndolesGLAXOSMITHKLINE LLC·Filed 2013·Granted Mar 10, 2015·12 cites·5 claims
- 0389US7166639B2NF-κB inhibitorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Jan 23, 2007·38 cites·17 claims
- 0488US9505745B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Nov 29, 2016·11 cites·20 claims
- 0587US9956210B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE LLC·Filed 2016·Granted May 1, 2018·2 cites·1 claims
- 0685US9556157B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2014·Granted Jan 31, 2017·8 cites·20 claims
- 0784US9073924B2AzaindazolesBURGESS JOELLE LORRAINE·Filed 2012·Granted Jul 7, 2015·5 cites·2 claims
- 0884US8637509B2AzaindazolesBURGESS JOELLE LORRAINE·Filed 2011·Granted Jan 28, 2014·12 cites·6 claims
- 0984US7109238B2Calcilytic compoundsNPS PHARMA INC·Filed 2004·Granted Sep 19, 2006·13 cites·6 claims
- 1079US9402836B2IndolesGLAXOSMITHKLINE LLC·Filed 2015·Granted Aug 2, 2016·2 cites·10 claims
- 1178US9790212B2Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2016·Granted Oct 17, 2017·2 cites·20 claims
- 1275US7087758B2Quinoline inhibitors of hyaki and hyak3 kinasesSMITHKLINE BEECHAM CORP·Filed 2002·Granted Aug 8, 2006·10 cites·9 claims
- 1371US6395919B1Calcilytic compoundsSMITHKLINE BEECHAM CORP·Filed 1999·Granted May 28, 2002·31 cites·13 claims
- 1470US8404837B2Quinoline derivatives as P13 kinase inhibitorsADAMS NICHOLAS D·Filed 2008·Granted Mar 26, 2013·1 cites·9 claims
- 1564US10478426B2Enhancer of Zeste Homolog 2 inhibitorsGLAXOSMITHKLINE LLC·Filed 2018·Granted Nov 19, 2019·0 cites·2 claims
- 1661US6294531B1Calcilytic compoundsSMITHKLINE BEECHAM CORP·Filed 1998·Granted Sep 25, 2001·21 cites·8 claims
- 1761US2014296224A1Quinoline derivatives as pi3 kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1854US2010179144A1Quinazoline derivatives as p13 kinase inhibitorsADAMS NICHOLAS D·Filed 2008·Application pending·0 cites
- 1954US2009018131A1Quinazoline derivatives as p13 kinase inhibitorsADAMS NICHOLAS D·Filed 2008·Application pending·0 cites
- 2047US2010179143A1Naphthyridine, derivatives as p13 kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 2141US7482455B2Chemical compoundsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 27, 2009·0 cites·4 claims
- 2240US2003018203A1Calcilytic compoundsFiled 2001·Application pending·0 cites
- 2340US2004039198A1CompoundsFiled 2001·Application pending·0 cites
- 2440US2004009980A1Calcilytic compoundsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →